Angiotensin I - converting enzyme (ACE) inhibitors

Details for Australian Patent Application No. 2006250905 (hide)

Owner University of Cape Town

Inventors Sturrock, Edward; Nchinda, Aloysius; Chibale, Kelly

Agent FB Rice

Pub. Number AU-B-2006250905

PCT Pub. Number WO2006/126086

Priority 2005/04366 27.05.05 ZA

Filing date 29 May 2006

Wipo publication date 30 November 2006

Acceptance publication date 9 June 2011

International Classifications

C07K 5/02 (2006.01) Peptides having up to four amino acids in a fully defined sequence

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/03 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in an undefined or only partially defined sequence

A61K 38/55 (2006.01) Medicinal preparations containing peptides - Protease inhibitors

C07C 225/00 (2006.01) Compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly-bound oxygen atoms not being part of a CHO group, e.g. amino ketones

C07K 14/81 (2006.01) Peptides having more than 20 amino acids - Protease inhibitors

Event Publications

20 December 2007 PCT application entered the National Phase

  PCT publication WO2006/126086 Priority application(s): WO2006/126086

9 June 2011 Application Accepted

  Published as AU-B-2006250905

6 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006250906-Angiotensin I-converting enzyme (ace) inhibitors

2006250889-A process comprising codon optimization for the production of recombinant activated human protein C for the treatment of sepsis